Locations:
Min Investment:
Max Investment:
Target Investment:
Master of Business Administration (MBA)
(1997 - 1998)
2019
2021
2019 - 2021
After 15 years developing new businesses for big corps and 6 years investing in innovative startups, I have decided to combine both. I have invested in Sentinhealth and will work hard to fund and bring to the market an AI-powered device that will hopefully move heart failure patients from emergency care to homecare.
2013
2013
Personal investments in 15 healthcare startups
2013 - 2019
Building the 1st private investor network dedicated to Healthcare in Europe. (100+ investors - 55 deals) Activity : Early-stage investment & business support for fast-growing companies. Scope : rounds of 500K-2.5 Mo€ in Biotech - Medtech - Diagnostics - Digital Health
2012 - 2012
2012 - 2012
Kick-off of Abbott Pharmaceuticals multi-stakeholder strategy in the field
2008 - 2011
2009 - 2011
Local execution of the European strategy: supporting sales & team transition in the French affiliate before restructuring
2008 - 2009
Head of commercial strategy & operations in Primary Care & Immuno-Neonat (500+ people - $850Mo sales) Primary Care : Product life-cycle management and transition from Rx to OTC business and Restructuring plan in affiliates where OTC is not an option. Hospital Neonatology (immunotherapy): building a cross-functional business team to design & implement a new way-to-market in affiliates. Develop multi-stakeholder strategies directed to prescribers, distributors, patients, payors, politicians.
2007 - 2007
2007 - 2007
Transition of 3M Pharma business to Meda
2004 - 2006
2005 - 2006
Sales & Marketing Strategy in Europe. New product development with the global team.
2004 - 2005
Launch of 1st in-class immunostimulator in skin cancer & HPV across 27 countries.
2003 - 2003
2003 - 2003
Launch of 1st patient campaign against HPV across Europe.
2001 - 2002
2001 - 2002
(3M corporate leadership program) Identification of new business opportunities for 3M Europe Board of Directors resulting in business unit openings and one global acquisition ($>1Bo). Consumer - Industrial - Healthcare Markets.
1999 - 2001
1999 - 2001
Launch of baby product range with KOLs in dermatology